Animal Models of LED-Induced Phototoxicity. Short- and Long-Term In Vivo and Ex Vivo Retinal Alterations
- PMID: 34833013
- PMCID: PMC8617611
- DOI: 10.3390/life11111137
Animal Models of LED-Induced Phototoxicity. Short- and Long-Term In Vivo and Ex Vivo Retinal Alterations
Abstract
Phototoxicity animal models have been largely studied due to their degenerative communalities with human pathologies, e.g., age-related macular degeneration (AMD). Studies have documented not only the effects of white light exposure, but also other wavelengths using LEDs, such as blue or green light. Recently, a blue LED-induced phototoxicity (LIP) model has been developed that causes focal damage in the outer layers of the superior-temporal region of the retina in rodents. In vivo studies described a progressive reduction in retinal thickness that affected the most extensively the photoreceptor layer. Functionally, a transient reduction in a- and b-wave amplitude of the ERG response was observed. Ex vivo studies showed a progressive reduction of cones and an involvement of retinal pigment epithelium cells in the area of the lesion and, in parallel, an activation of microglial cells that perfectly circumscribe the damage in the outer retinal layer. The use of neuroprotective strategies such as intravitreal administration of trophic factors, e.g., basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF) or pigment epithelium-derived factor (PEDF) and topical administration of the selective alpha-2 agonist (Brimonidine) have demonstrated to increase the survival of the cone population after LIP.
Keywords: LED induced phototoxicity; cone photoreceptor; microglia activation; neuroprotection; retinal pigment epithelium.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Friedman D.S., O’Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., Kempen J., Eye Diseases Prevalence Research G. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004;122:564–572. - PubMed
-
- Wong W.L., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health. 2014;2:e106–e116. doi: 10.1016/S2214-109X(13)70145-1. - DOI - PubMed
-
- Nowak J.Z. AMD—The retinal disease with an unprecised etiopathogenesis: In search of effective therapeutics. Acta Pol. Pharm. 2014;71:900–916. - PubMed
Publication types
Grants and funding
- 19881/GERM/15/Fundación Séneca, Agencia de Ciencia y Tecnología Región de Murcia
- RED2018-102499-T/Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III
- PI19/00203/Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III
- RD16/0008/0026/Ministry of Economy and Competitiveness
- PID2019-106498GB-I00/Spanish Ministry of Science and Innovation
LinkOut - more resources
Full Text Sources
Miscellaneous
